Recommended Gap Between Cosentyx Doses and Vaccinations
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses immune responses, raising infection risks from live vaccines. No universal "gap" applies to all vaccines, but guidelines prioritize live vaccines and timing around the drug's half-life of about 27 days.[1]
Live Vaccines: Avoid During Treatment and Before Starting
Do not give live or live-attenuated vaccines (e.g., MMR, varicella, oral polio, yellow fever, nasal flu) to patients on Cosentyx. Wait 4-6 weeks after the last dose before vaccinating with live vaccines, as secukinumab levels drop enough for immune recovery. Before starting Cosentyx, complete live vaccines 4 weeks prior to allow antibody response.[1][2]
Inactivated Vaccines: Safe During Treatment
Inactivated or subunit vaccines (e.g., flu shot, Tdap, HPV, shingles recombinant like Shingrix, COVID-19 vaccines) can be given anytime, including during Cosentyx treatment. Response may be reduced, so check titers if high-risk.[1][2][3]
Timing Around Cosentyx Dosing
- Before first dose: Finish live vaccines 4 weeks prior.
- During treatment: Use inactivated vaccines; hold live ones.
- After stopping: Wait 4 weeks post-last dose for live vaccines.
Loading doses (weeks 0, 1, 2, 3, 4) heighten suppression, so delay non-urgent live vaccines longer.[1]
| Vaccine Type | Recommended Gap from Cosentyx |
|--------------|-------------------------------|
| Live/Attenuated | 4 weeks after last dose; 4 weeks before starting |
| Inactivated | No gap needed |
Patient and Clinical Considerations
Immunocompromised patients on Cosentyx show adequate responses to most inactivated vaccines, but pneumococcal and meningococcal may need boosters. Consult infectious disease specialists for travel or outbreak risks. Real-world data confirms low serious infection rates post-vaccination.[3][4]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: CDC Guidelines on Immunization for Immunocompromised Adults
[3]: Novartis Cosentyx Vaccination Study (PubMed)
[4]: ACR Guidelines for Vaccinations in Rheumatic Diseases